MiRNA-based therapy for Psoriasis: MiRNA-520c inhibits psoriasiform skin inflammation via down regulation of its target gene, 05/October/2014, 07.40 am

A recent study from the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; and Institute for Biomedical Research, University College London, London, UK shows that “Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.” This study was published in the Apr 23  2014 Nature by Prof Ulrich H. von Andrian, Lorena Riol-Blanco, and others. On the foundation of this interesting finding, Dr […]

Expose yourself to optimal Sunlight to live longer: Nitric oxide increases male life span via down regulation of its target gene, 05/October/2014, 07.00 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan,  Expose yourself to optimal Sunlight to live longer: Nitric oxide increases male life span via down regulation of its target gene, 05/October/2014, 07.00 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation Significance: This study provides therapeutic insights into increasing the life expectancy […]

Anti-cancer stem cell therapeutics: NR2F2 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via down regulation of its target genes, 05/October/2014, 06.11 am

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the University of Colorado BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function. In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Anti-cancer stem cell therapeutics: NR2F2  suppresses […]